Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



OPINION by Janice Dean: Dear viewer, MS taught me that my big strong legs are not ugly, they're a blessing

I get a few rude comments on my Facebook page from time to time, like the one below, that I’ve decided to share with everyone:

“Dear Janice please stop allowing fox to dress you in those short skirts. They are not flattering on you. Your an attractive lady, love the 80's hair, but your legs are distracting every time you walk on screen.”
Read more »


Asthma Drug May Slow Brain Damage in MS: VIDEO

There is some encouraging news for people with the most severe and disabling form of MS.

As CBS2’s Dr. Max Gomez reports, an asthma drug from Japan may slow brain damage in MS patients.
Read more »



Low dose naltrexone (LDN) in MS: Effects on medication use. A quasi-experimental study

Low dose naltrexone (LDN) has become a popular off-label therapy for multiple sclerosis (MS). A few small, randomized studies indicate that LDN may have beneficial effects in MS and other autoimmune diseases. If proven efficacious, it would be a cheap and safe alternative to the expensive treatments currently recommended for MS. We investigated whether a sudden increase in LDN use in Norway in 2013 was followed by changes in dispensing of other medications used to treat MS. We performed a quasi-experimental before–and–after study based on population data from the Norwegian Prescription Database (NorPD). We included all patients that collected at least one LDN prescription in 2013, and had collected at least two medications with a reimbursement code for MS, or collected a medication with MS as the only indication in 2009 or 2010.
Read more »



Computational simulations suggest MS is a single disease

Findings support hypothesis that the same mechanisms underlie widely varying symptoms
The diverse phenotype of MS is the consequence of the dynamic damage to the brain. Chronic autoimmune inflammatory damage to the brain produces waves of demyelination (blue line in the graph) and cumulative axonal loss (green line in the graph) in different intensities along time leading to all MS phenotypes.
Credit: Dr Santiago Ortiz-Perez, from the Institute of Ophthalmology and Center of Neuroimmunology, IDIBAPS - Hospital Clinic, University of Barcelona.

New research supports the idea that MS, which has widely varying symptoms and progression in different patients, is nonetheless a single disease with common underlying mechanisms. The findings are published in PLOS Computational Biology.
Read more »


Upper Extremity Composite Picks Up Early MS

Image Source: BLOGSPOT

Outperformed individual tests that may be less sensitive

A composite score for upper extremity function in multiple sclerosis was more sensitive than individual traditional tests in a small trial, and correlated well with neuroimaging markers of disability, researchers reported here.

Read more »


Does Exercise Improve Quality of Life for Those with MS?

A new study investigates if physical exercise improves functional capacity and quality of life for those diagnosed with MS.
Read more »

Labels: ,


Accepting that Sometimes, We Need Rest

By the grace of God, I am a naturally positive individual who lends optimism and hope to even the bleakest of situations. Because of this, it is difficult to find me in a situation when my auspicious nature tires; after all, we find out the most about ourselves when facing adversity.
Read more »


Allergy Drug Improves Function in Patients with Chronic Injury from MS

Jonah R. Chan (left), PhD, and Ari Green, MD, published a paper with results that show an over-the-counter drug restored nervous system function in patients with chronic MS.
Photo by Steve Babuljak

In Phase II Clinical Trial, Over-the-Counter Antihistamine Significantly Accelerated Nerve-Cell Signaling that had been Slowed by MS

In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic MS.
Read more »


Useful Tips for Managing Cognitive Health With MS

According to the National Multiple Sclerosis Society, around 65 percent of people living with the disease suffer from some cognitive issues — most notably, memory, concentration and speed of processing information.
Read more »



Transcranial Direct Current Stimulation Shown to Reduce Fatigue Associated with MS

People with MS who underwent a non-invasive form of electrical brain stimulation experienced significant reductions in fatigue, a common and often debilitating symptom of the disease, according to new research from the Multiple Sclerosis Comprehensive Care Center at NYU Langone Health.
Read more »

Labels: ,


Mylan says FDA approves its generic MS treatment

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. U.S. REUTERS/Jason Reed

Mylan NV said the U.S. Food and Drug Administration has approved two doses of its generic version of Teva’s Copaxone used to treat patients with relapsing forms of MS.
Read more »



5 questions: making MS care more patient-centric

Trishna Bharadia, MS patient advocate, talks about her goal to make MS care more patient-centric, ahead of her talk at the eyeforpharma Patient Summit Europe.

Trishna Bharadia was first diagnosed with relapsing and remitting MS in 2008, at the age of 28. However, not content to simply manage her own condition, Trishna has become an advocate for other people with MS, and campaigns for better NHS services and more true ‘patient centricity’.
Read more »


Congressman urges President Trump to take action on $90,000 MS drug

House Oversight Committee ranking member Rep. Elijah Cummings (D-Md.).
Getty Images

Cummings said the president could ‘make a deal’ to lower Zinbryta’s price

Rep. Elijah Cummings (D-Md.) urged President Donald Trump to help lower the price of a $90,000-a-year MS drug on Thursday.
Read more »


Unique gene therapy prevents, reverses MS in animal model

MS can be inhibited or reversed using a novel gene therapy technique that stops the disease’s immune response in mouse models, University of Florida Health researchers have found.
Read more »

Go to Older News